Industry News (Joint Venture)

Infectious Disease Research and Development Collaboration Announced

Published in Vaccine Weekly, October 23rd, 1995

Corixa Corporation, Seattle, Washington, announced the signing of a technology-based collaboration with SB Biologicals, the vaccine producing subsidiary of SmithKline Beecham (SB).

The collaboration will provide Corixa with significant funding to support its research and development activities aimed at the generation of T-cell active vaccines for infectious disease applications. In exchange for committed, multi-year funding directed toward new vaccine development for a specific disease target, SB will receive options to license Corixa discovered vaccines in exchange for payment to Corixa of license fees, milestone fees (upon successful completion of development...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-10-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry